“FEATURES OF THE PHARMACOEPIDEMIOLOGICAL DESCRIPTION OF POST-COVID-19 AHAB IN WOMEN”. 2025. The Conference Hub, August, 53-56. https://theconferencehub.com/index.php/tch/article/view/429.